Other Serious Risks Intestinal Blockage (Ileus) Added to Label: September 2023 Symptoms: Severe abdominal pain, inability to pass gas or stool, severe bloating, vomiting Risk: Can require emergency surgery to correct Pancreatitis Added to Label: January 2025 Symptoms: Severe upper abdominal pain, nausea, vomiting, fever Risk: Necrotizing pancreatitis can be life-threatening Kidney Injuries Added to Label: January 2025 Cause: Often related to severe dehydration from persistent vomiting Risk: Acute kidney injury requiring hospitalization Gallbladder Disease Research: 2023 JAMA study linked higher doses to increased risk Symptoms: Severe pain in upper right abdomen, nausea, jaundice Outcome: Often requires gallbladder removal surgery The Side Effects Everyone Gets (But Still Takes the Drug) Nausea: ~50% of users (RAND survey) Diarrhea: ~33% of users Stopped Due to Side Effects: 13% of users Stopped Due to Cost: 14% of users According to the RAND American Life Panel survey of 8,793 Americans, about half of GLP-1 users experienced nausea and roughly one-third experienced diarrhea
E., Tarragon E., Campuzano C
Note: Always check your medications label and use the original packaging to shield the pen from light
The Victorian Cancer Biobank (VCB), which collects tissue, blood and data for cancer research and clinical trials in Victoria, hopes that this new technology may one day allow us to manage cancer reoccurrence as easily as monitoring blood sugar levels for diabetic patients
